文献速递胸部技术与安全SPECT/CTPET/CT

99mTc-3PRGD2 SPECT/CT显像诊断原发性肺部恶性肿瘤淋巴结转移

99mTc-3PRGD2 SPECT/CT Imaging for Diagnosing Lymph Node Metastasis of Primary Malignant Lung Tumors.
PubMed 文献 · Korean J Radiol · 2023-01-01

前瞻性纳入26例原发性肺部恶性肿瘤患者,行99mTc-3PRGD2 SPECT/CT与18F-FDG PET/CT显像,以病理为参考标准。99mTc-3PRGD2 SPECT/CT半定量分析诊断淋巴结转移的AUC为0.908,敏感度0.86、特异度0.88;原发灶半定量摄取在有无淋巴结转移组间差异有统计学意义(P=0.007,AUC=0.807)。

要点

  • 99mTc-3PRGD2 SPECT/CT半定量分析诊断淋巴结转移AUC 0.908,敏感度0.86、特异度0.88。
  • 原发灶半定量摄取可间接预测淋巴结转移,AUC 0.807(95%CI 0.641-0.974)。
  • 淋巴结转移与良性淋巴结的视觉定性及半定量分析差异均有统计学意义(P<0.001)。

核心结论

  • 99mTc-3PRGD2 SPECT/CT显像可能对原发性肺部恶性肿瘤淋巴结转移的直接诊断表现良好,并可通过原发灶摄取间接预测淋巴结转移的存在。

研究设计与样本

  • 前瞻性纳入26例原发性肺部恶性肿瘤患者,均行99mTc-3PRGD2 SPECT/CT与18F-FDG PET/CT显像,以组织病理学结果为参考标准,在淋巴结站水平和患者水平分析。

关键影像表现/征象

  • 转移性与良性淋巴结在99mTc-3PRGD2 SPECT/CT和18F-FDG PET/CT的视觉定性及半定量分析中差异均有统计学意义(均P<0.001)。
  • 26例患者(含2例各有两个肺部肿瘤)中15例病理证实淋巴结转移。
  • 原发肺部病灶在有无淋巴结转移患者间的差异仅在99mTc-3PRGD2 SPECT/CT半定量分析中有统计学意义(P=0.007),AUC为0.807(95%CI 0.641-0.974)。

诊断标准与关键数值

  • 99mTc-3PRGD2 SPECT/CT半定量分析诊断淋巴结转移的AUC为0.908(95%CI 0.851-0.966)。
  • 99mTc-3PRGD2 SPECT/CT半定量分析诊断淋巴结转移的敏感度0.86(36/42)、特异度0.88(120/136)、阳性预测值0.69(36/52)、阴性预测值0.95(120/126)。
  • 原发灶半定量分析预测淋巴结转移的AUC为0.807(95%CI 0.641-0.974)。

临床应用与阅片要点

  • 99mTc-3PRGD2 SPECT/CT半定量分析可用于直接评估淋巴结转移,阴性预测值0.95(120/126)。
  • 原发灶99mTc-3PRGD2摄取半定量分析可能间接提示淋巴结转移的存在。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate 99mtechnetium-three polyethylene glycol spacers-arginine-glycine-aspartic acid (99mTc-3PRGD2) single-photon emission computed tomography (SPECT)/computed tomography (CT) imaging for diagnosing lymph node metastasis of primary malignant lung neoplasms.

MATERIALS AND METHODS: We prospectively enrolled 26 patients with primary malignant lung tumors who underwent 99mTc-3PRGD2 SPECT/CT and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/CT imaging. Both imaging methods were analyzed in qualitative (visual dichotomous and 5-point grades for lymph nodes and lung tumors, respectively) and semi-quantitative (maximum tissue-to-background radioactive count) manners for the lymph nodes and lung tumors. The performance of the differentiation of lymph nodes with and without metastasis was determined at the per-lymph node station and per-patient levels using histopathological results as the reference standard.

RESULTS: Total 42 stations had metastatic lymph nodes and 136 stations had benign lymph nodes. The differences between metastatic and benign lymph nodes in the visual qualitative and semiquantitative analyses of 99mTc-3PRGD2 SPECT/CT and 18F-FDG PET/CT were statistically significant (all P < 0.001). The area under the receiver operating characteristic curve (AUC) in the semi-quantitative analysis of 99mTc-3PRGD2 SPECT/CT was 0.908 (95% confidence interval [CI], 0.851-0.966), and the sensitivity, specificity, positive predictive value, and negative predictive value were 0.86 (36/42), 0.88 (120/136), 0.69 (36/52), and 0.95 (120/126), respectively. Among the 26 patients (including two patients each with two lung tumors), 15 had pathologically confirmed lymph node metastasis. The difference between primary lung lesions in patients with and without lymph node metastasis was statistically significant only in the semi-quantitative analysis of 99mTc-3PRGD2 SPECT/CT (P = 0.007), with an AUC of 0.807 (95% CI, 0.641-0.974).

CONCLUSION: 99mTc-3PRGD2 SPECT/CT imaging may notably perform in the direct diagnosis of lymph node metastasis of primary malignant lung tumors and indirectly predict the presence of lymph node metastasis through uptake in the primary lesions.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Xiao L, Yu S, Xu W, et al. 99mTc-3PRGD2 SPECT/CT Imaging for Diagnosing Lymph Node Metastasis of Primary Malignant Lung Tumors. Korean J Radiol. 2023. PMID: 37899523. doi:10.3348/kjr.2023.0411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。